A novel protein‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patients
暂无分享，去创建一个
I. Wistuba | C. Behrens | M. Pajares | J. Pérez-Gracia | L. Millares | E. Monso | L. Montuenga | R. Pio | J. Agorreta | M. Lozano | J. Zulueta | F. D. de Miguel | Elena Martínez-Terroba | C. Sainz | M. Mesa-Guzmán | Fernando J. de Miguel